Navigation Links
Vaginal Mesh and Kugel Hernia Mesh Case Applications for Lawsuit Funding on the Rise at Legal-Bay Settlement Funding

NEW YORK, April 3, 2012 /PRNewswire/ -- Legal-Bay, announced today that their applications for Transvaginal Mesh cases and Kugel Hernia Mesh cases have risen sharply since the company began funding plaintiffs for Mesh cash advances beginning in January 2012.  Most companies within the legal funding industry do not fund Vaginal Mesh or Hernia Mesh Patch cases; however Legal-Bay is an industry leader who is one of the few companies now offering plaintiffs the needed cash to live before their cases go to trial or are settled. 

Settlement Funding experts expect the Transvaginal Mesh cases to go to trial in NJ in 2012, if a global settlement cannot be worked out.  Although the rest of the industry is being very cautious with Mesh cases by refusing to fund plaintiffs of these cases; Legal-Bay stands ready to assist the plaintiffs now – without even knowing the outcome of the litigation.  Not only that, Legal-Bay believes the cases are worth a substantial amount in which Mesh victims can apply for up to $50,000.00 in what is referred to by plaintiffs as a "lawsuit loan".  However, the cash advance is a non-recourse loan in which the victim will owe nothing back if the case ultimately fails. 

Patty Kirby, Head of Customer Relations, commented about the firm's policy on Vaginal and Hernia Mesh settlement funding, "Our product liability funding division has been very busy helping victims of the DePuy Hip Recall, as well as the Vaginal Mesh and Hernia Mesh Cases who have been seeking funding for months and have had no other funders willing to help.  We have secured ample financing to get these individuals lawsuit cash today, regardless of the outcome of their case.  That is what makes our policy different from the rest of the industry; we are not taking a 'wait and see approach', but instead are helping these victims get the money they need today." 

All DePuy, Vaginal and Hernia Mesh victims can apply online at or by calling Legal-Bay's 24hr toll free hotline at 877.571.0405, where live agents are standing by 24 hours a day.

Patty Kirby, Director of Client Relations
Ph. 877.571.0405

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem
2. Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%
3. Ohio Injury Lawyers Support FDAs Decision for Further Testing of Transvaginal Mesh
4. New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
5. Columbia Laboratories NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA
6. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
7. Plexus Biomedical Inc. Gains FDA Approval of the First Medical Device to Help Prevent External Hemorrhoids During Vaginal Childbirth
8. Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity
9. International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women
10. Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
11. China Sky One Medical Obtains SFDA Approval for Ciclopirox Olamine Vaginal Suppositories
Post Your Comments:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):